Resistant hypertension at a glance
Resistant, especially young: think secondary. Safety first, then K⁺ and HCO₃ point the way.
- Definition and target-organ damage Confirm true resistance; exclude target-organ damage.
- Potassium and acid-base triage K⁺ and HCO₃ split the differential.
- Lesion-directed therapy Channel, receptor, transporter or ACTH: lesion picks the drug.
-
Stop 1 · Assessment
Definition and initial assessment
Young or severe: target-organ damage before any secondary workup.
Definition · 2025 AHA/ACCUncontrolled on ≥3 drugs incl. a diuretic, maximal tolerated dose; or controlled on ≥4.
Young or severe · firstFundoscopy, ECG, creatinine, neurological status.
No acute organ damage
Adjust oral therapy, prompt follow-up.
Hypertensive emergency
Monitored setting, titratable IV agent. SBP ↓ no more than 25% in hour 1 → below 160/100 over 2–6 h → normal over 24–48 h (organ-specific exceptions).
Exclude pseudoresistance
- Adherence, cuff size
- ABPM / home BP: white-coat effect
- NSAIDs, decongestants, OCP, steroids
- Salt intake, adequate diuretic dose
Clinical clues to secondary causes
- Onset <20, or family PA / haemorrhagic stroke <40 → GRA
- Bruit, flash pulmonary oedema, young woman → RAS / FMD
- Radiofemoral delay → coarctation
- Labile BP, palpitations, headache, sweating → pheochromocytoma
Memory hook≥3drugs +1diuretic maxdose orcontrolled ≥4drugsAdd-on: spironolactone beats other agents (PATHWAY-2). Renal denervation: who benefits still undefined, not routine first-line.
-
Stop 2 · Investigations
Potassium and acid-base triage
Subscribers only
Unlock the other 5 stops
Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.
- Renin–aldosterone patterns
- Primary aldosteronism
- Low-renin, low-aldosterone hypertension
- Gordon syndrome (PHA-II)